Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
BioNexus Gene Lab Corp. (BGLC) had Earnings per Share (EPS) (Basic) of $-0.23 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-0.54M |
|
$0.02M |
|
$-0.00M |
|
$0.56M |
|
$-0.54M |
|
$-0.00M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$-0.54M |
|
$-0.52M |
|
$-0.48M |
|
2.42M |
|
2.42M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.23 |
$-0.23 |
|
| Balance Sheet Financials | |
$5.20M |
|
$1.58M |
|
$3.84M |
|
$9.04M |
|
$0.80M |
|
$0.05M |
|
$0.15M |
|
$0.95M |
|
$8.09M |
|
$8.09M |
|
$8.09M |
|
2.42M |
|
| Cash Flow Statement Financials | |
$-0.15M |
|
$-0.01M |
|
$0.06M |
|
$2.49M |
|
$2.40M |
|
$-0.09M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.52 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-3.46% |
|
-2366.21% |
|
-2291.00% |
|
-- |
|
-2379.72% |
|
-2379.72% |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.04 |
|
0.10 |
|
908.01 |
|
-6.72% |
|
-6.72% |
|
-6.01% |
|
-6.68% |
|
$3.35 |
|
$-0.06 |
|
$-0.06 |
|